Expression of concern

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study

Paper Information

Record ID:
35467
Author(s):
Heather Wilson
George Dervenoulas
Gennaro Pagano
Christos Koros
Tayyabah Yousaf
Marina Picillo
Sotirios Polychronis
Athina Simitsi
Beniamino Giordano
Zachary Chappell
Benjamin Corcoran
Maria Stamelou
Roger N Gunn
Maria Teresa Pellecchia
Eugenii A Rabiner
Paolo Barone
Leonidas Stefanis
Marios Politis
Journal:
The Lancet Neurology ( Elsevier )
Publication Date:
June 19, 2019
Retraction Date:
January 18, 2022 (3.8 years years ago)
Subjects:
Broad Categories:
Medicine Genetics Biostatistics/Epidemiology
Institutions:
Countries:
🇩🇪 Germany 🇬🇷 Greece 🇮🇹 Italy 🇬🇧 United Kingdom
Article Type:
Clinical Study
Publisher:
Elsevier
Open Access:
Yes
DOI:
10.1016/S1474-4422(19)30140-1
PubMed ID:
31229470
Retraction PubMed ID:
35063117

Expression of concern Details

Retraction Reasons:
Nature of Retraction:

Expression of concern

Retraction Notice:
10.1016/S1474-4422(22)00030-8

Citations (87)

87
Total Citations
45
Post-Retraction
(51.7%)
41
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
16 Within 1 year
19 After 2+ years
1267 Days since retraction (latest)
The effects of high-altitude hypoxic environment on the pharmacokinetics and respiratory function of remimazolam: an experimental study in rats
Qingbin Chen, Li Deng, Zhen Jia
Scientific Reports Open Access
Published: Jul 2025
1267 days after retraction
Early diagnosis of Parkinson’s disease: biomarker study
Jing Li, Mei Zhang, Chuan-Qing Yu et al. (5 authors)
Frontiers in Aging Neuroscience Open Access
Published: May 2025
1207 days after retraction
Comparative analysis of Parkinson’s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion
Maeve E. Krueger, Jake Boles, Zachary D. Simon et al. (9 authors)
npj Parkinson s Disease Open Access
Published: Mar 2025
5 citations
1156 days after retraction
Prodromal Parkinson’s Disease
Iro Boura, Karolina Popławska-Domaszewicz, Naomi Limbachiya et al. (6 authors)
Neurologic Clinics
Published: Jan 2025
1 citation
1100 days after retraction
Preserved Serotonin Transporter Availability in Parkinson Disease Measured with Either [<sup>11</sup>C]MADAM or [<sup>11</sup>C]DASB: A Study Including 2 Separate Cohorts of Nondepressed Patients
Minyoung Oh, Joachim Brumberg, Vesna Sossi et al. (4 authors)
Journal of Nuclear Medicine
Published: Jan 2025
1080 days after retraction
Longitudinal Trajectory of Dopamine and Serotonin Transporters in Parkinson Disease
Yu-Jin Song, Jae‐Hyeok Lee, Han‐Kyeol Kim et al. (7 authors)
Journal of Nuclear Medicine
Published: Jan 2025
1080 days after retraction
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Dayamrita Kollaparampil Kishanchand, Athira Krishnan K. A., Krishnapriya Chandrababu et al. (6 authors)
Journal of Neuroscience Research
Published: Jan 2025
1 citation
1079 days after retraction
Serum neurotransmitter analysis of motor and non-motor symptoms in Parkinson’s patients
Yichun Fan, Wenping Yang, Weilan Wu et al. (10 authors)
Frontiers in Aging Neuroscience Open Access
Published: Nov 2024
2 citations
1042 days after retraction
The effect of serotonin reuptake and serotonin-noradrenaline reuptake inhibitors on motor symptoms in Parkinson's disease: A PPMI-based matched-subject study
Teodora Matić, Martijn Hendriks, Saman Vinke et al. (5 authors)
Journal of Parkinson s Disease Open Access
Published: Nov 2024
1 citation
1029 days after retraction
Translating Therapeutic Strategies for Genetic Parkinson’s Disease Syndromes
Susanne A. Schneider, Roy N. Alcalay
Neuromethods
Published: Sep 2024
974 days after retraction
Simulating combined monoaminergic depletions in a PD animal model through a bio-constrained differential equations system
Samuele Carli, Luigi Brugnano, Daniele Caligiore
Frontiers in Computational Neuroscience Open Access
Published: Aug 2024
948 days after retraction
Mapping the distribution of neurotransmitters to resting-state functional connectivity in patients with Parkinson’s disease
Paola Piccini, Weihua Li, Nicholas P Lao–Kaim et al. (18 authors)
Research Square (Research Square)
Published: Jul 2024
912 days after retraction
Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem
Wei‐Hua Chiu, Nadine Wattad, Joshua A. Goldberg
Pharmacology & Therapeutics
Published: Jun 2024
4 citations
893 days after retraction
Parkinson’s Disease Recognition Using Decorrelated Convolutional Neural Networks: Addressing Imbalance and Scanner Bias in rs-fMRI Data
Pranita Patil, W. Randolph Ford
Biosensors Open Access
Published: May 2024
4 citations
852 days after retraction
A comparative analysis of Parkinson’s disease and inflammatory bowel disease gut microbiomes highlights shared depletions in key butyrate-producing bacteria
Maeve E. Krueger, Jake Boles, Zachary D. Simon et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Published: Apr 2024
2 citations
832 days after retraction
Vocal and tongue exercise in early to mid-stage Parkinson disease using the Pink1-/- rat
Jesse D. Hoffmeister, Courtney K. Broadfoot, Nicole E. Schaen‐Heacock et al. (12 authors)
Brain Research Open Access
Published: Apr 2024
2 citations
830 days after retraction
Aging accelerates locomotor decline in PINK1 knockout rats in association with decreased nigral, but not striatal, dopamine and tyrosine hydroxylase expression
Isabel Soto, Robert McManus, Walter Navarrete et al. (7 authors)
Experimental Neurology Open Access
Published: Apr 2024
3 citations
807 days after retraction
Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson’s Disease
Jiaqi Niu, Yan Zhong, Chentao Jin et al. (10 authors)
Neuroscience Bulletin
Published: Mar 2024
4 citations
786 days after retraction
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan et al. (10 authors)
Signal Transduction and Targeted Therapy Open Access
Published: Feb 2024
332 citations
759 days after retraction
The habenula in Parkinson's disease: Anatomy, function, and implications for mood disorders − A narrative review
Bedia Samancı, Sonny Tan, Stijn Michielse et al. (5 authors)
Journal of Chemical Neuroanatomy Open Access
Published: Jan 2024
2 citations
729 days after retraction
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek et al. (9 authors)
Biomolecules Open Access
Published: Jan 2024
9 citations
717 days after retraction
Integrated Bioinformatics Analysis Reveals the Aberrantly Methylated Differentially Expressed Genes in Dilated Cardiomyopathy
Nana Li, Jinglin Wang, Xuhong Wang et al. (4 authors)
International Journal of Medical Sciences Open Access
Published: Jan 2024
713 days after retraction
Tongue and laryngeal exercises improve tongue strength and vocal function outcomes in a Pink1-/- rat model of early Parkinson disease
Courtney K. Broadfoot, Jesse D. Hoffmeister, Sarah Lechner et al. (11 authors)
Behavioural Brain Research
Published: Nov 2023
3 citations
671 days after retraction
Dysfunctional dorsal raphe dopaminergic neurons and locus coeruleus noradrenergic neurons cause anxiety and depression in a Parkinson’s disease mouse model
Rosario Moratalla, Adrián Sanz‐Magro, Noelia Granado et al. (11 authors)
Research Square (Research Square) Open Access
Published: Oct 2023
1 citation
633 days after retraction
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi et al. (10 authors)
Trends in Food Science & Technology Open Access
Published: Jun 2023
163 citations
509 days after retraction
Serotonin in synucleinopathies
Ohnmar Hsam, Zacharias Kohl
Behavioural Brain Research
Published: Mar 2023
8 citations
412 days after retraction
The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
Lluís Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado et al. (5 authors)
Biomedicines Open Access
Published: Feb 2023
23 citations
391 days after retraction
Translational molecular imaging and drug development in Parkinson’s disease
Ahmed Haider, Nehal H. Elghazawy, Alyaa Dawoud et al. (9 authors)
Molecular Neurodegeneration Open Access
Published: Feb 2023
35 citations
388 days after retraction
Reduced platelet 5-HT content is associated with rest tremor in Parkinson's disease
Jianyong Wang, Jin-Yu Chen, Yi-Zhi Lian et al. (9 authors)
Parkinsonism & Related Disorders
Published: Feb 2023
5 citations
380 days after retraction
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Zachary D. Wallen, Ayşe Demirkan, Guy Twa et al. (8 authors)
Nature Communications Open Access
Published: Nov 2022
212 citations
301 days after retraction
Dopaminergic molecular imaging in familial and idiopathic Parkinson's disease
Edoardo Rosario de Natale, Heather Wilson, Marios Politis
Elsevier eBooks
Published: Nov 2022
1 citation
297 days after retraction
Molecular imaging in prodromal Parkinson’s disease
Edoardo Rosario de Natale, Joji Philip Verghese, Heather Wilson et al. (4 authors)
Elsevier eBooks
Published: Nov 2022
297 days after retraction
Serotonergic molecular imaging in familial and idiopathic PD
Gennaro Pagano
Elsevier eBooks
Published: Nov 2022
297 days after retraction
The pathobiological basis of depression in Parkinson disease: challenges and outlooks
K. A. Jellinger
Journal of Neural Transmission Open Access
Published: Nov 2022
34 citations
288 days after retraction
The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
Daniele Caligiore, Flora Giocondo, Massimo Silvetti
IBRO Neuroscience Reports Open Access
Published: Sep 2022
15 citations
251 days after retraction
Imaging the Limbic System in Parkinson’s Disease—A Review of Limbic Pathology and Clinical Symptoms
Magdalena Banwinkler, Hendrik Theis, Stéphane Prange et al. (4 authors)
Brain Sciences Open Access
Published: Sep 2022
43 citations
240 days after retraction
Molecular Imaging in Parkinsonian Disorders—What’s New and Hot?
Stéphane Prange, Hendrik Theis, Magdalena Banwinkler et al. (4 authors)
Brain Sciences Open Access
Published: Aug 2022
13 citations
221 days after retraction
Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson’s Disease
Elissavet-Kalliopi Akrioti, Timokratis Karamitros, Panagiotis Gkaravelas et al. (6 authors)
Biomolecules Open Access
Published: Jun 2022
7 citations
156 days after retraction
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Zachary D. Wallen, Ayşe Demirkan, Guy Twa et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Jun 2022
7 citations
145 days after retraction
Potential roles of branched-chain amino acids in neurodegeneration
Hyung-Suk Yoo, Ushananthini Shanmugalingam, Patrice D. Smith
Nutrition
Published: Jun 2022
21 citations
136 days after retraction
Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment
Stéphane Prange, Hélène Klinger, Chloé Laurencin et al. (5 authors)
Drugs & Aging Open Access
Published: Jun 2022
93 citations
134 days after retraction
An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in Drosophila melanogaster
Rafaella V. Zárate, Sergio Hidalgo, Nicole Navarro et al. (10 authors)
Cells Open Access
Published: May 2022
7 citations
107 days after retraction
Limbic Serotonergic Plasticity Contributes to the Compensation of Apathy in Early Parkinson's Disease
Stéphane Prange, Élise Météreau, Audrey Maillet et al. (14 authors)
Movement Disorders
Published: Mar 2022
20 citations
44 days after retraction
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Siyu Dong, Miao‐Kun Sun, Chuan He et al. (4 authors)
Brain Research Bulletin
Published: Mar 2022
26 citations
42 days after retraction
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy
Lluís Miquel-Rio, Diana Alarcón-Arís, María Torres‐López et al. (14 authors)
Translational Psychiatry Open Access
Published: Feb 2022
38 citations
37 days after retraction
Expression of concern—Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
The Editors
The Lancet Neurology Open Access
Published: Jan 2022
Same day as retraction
Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
Leslie C. Jellen, Mechelle M. Lewis, Guangwei Du et al. (14 authors)
Scientific Reports Open Access
Published: Dec 2021
12 citations
28 days before retraction
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa, Guglielmo Foffani, Benjamin Dehay et al. (5 authors)
Nature reviews. Neuroscience
Published: Dec 2021
168 citations
35 days before retraction
Asymptomatic carriers of the p.A53T SNCA mutation: data from the PPMI study
Athina Maria Simitsi, Christos Koros, María Stamelou et al. (15 authors)
medRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Dec 2021
44 days before retraction
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank Boess, Kirsten I. Taylor et al. (26 authors)
Frontiers in Neurology Open Access
Published: Oct 2021
65 citations
109 days before retraction
Quick Stats
Total Citations: 87
Years Since Retraction: 3.8 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Early Identification of DMD in the Setting of West Syndrome
Child Neurology Open • 0 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice